Agouron Pharmaceuticals Inc. on Wednesday said it hascompleted a public offering of 2 million shares at $19.25 pershare. Of those shares, 60,000 were sold by a sellingshareholder and 1.94 million were issued by the La Jolla,Calif., company. Agouron grossed $37.3 million. After theoffering, the maker of drugs based on the molecular structuresof proteins has 6.8 million shares outstanding.
Underwriters PaineWebber Inc., Smith Barney, Harris Upham &Co. Inc. and Hambrecht & Quist Inc. have an overallotmentoption of 300,000 shares, including 40,000 shares from theselling stockholder.
Agouron stock (NASDAQ:AGPH) on Wednesday closed down 13cents at $19.63.
(c) 1997 American Health Consultants. All rights reserved.